Filing Flows › Comparisons › SKVI vs BOLT
Skinvisible vs Bolt Biotherapeutics: SKVI and BOLT compared
Skinvisible is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $5K for Bolt Biotherapeutics (Q2 2026). Skinvisible is growing faster (0% against -100% a year earlier).
Where the money goes: SKVI and BOLT
Skinvisible (SKVI) · Q2 2026
Skinvisible, Q2 2026: revenue $5K (0% year over year), net loss $256K, operating cash flow $2K. The chart follows the revenue to costs, profit and cash.
Bolt Biotherapeutics (BOLT) · Q2 2026
Bolt Biotherapeutics, Q2 2026: revenue $5K (-100% year over year), net loss $7.7M, operating cash flow −$6.5M. The chart follows the revenue to costs, profit and cash.
| Skinvisible (SKVI) | Bolt Biotherapeutics (BOLT) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $5K | $5K |
| Revenue growth, Y/Y | 0% | -100% |
| Operating margin | n/m | n/m |
| Net earnings | −$256K | −$7.7M |
| Operating cash flow | $2K | −$6.5M |
Questions
Which is bigger, Skinvisible or Bolt Biotherapeutics?
Skinvisible is the larger company: $5K of revenue in its latest quarter (Q2 2026) against $5K for Bolt Biotherapeutics (Q2 2026).
Is Skinvisible or Bolt Biotherapeutics growing faster?
Skinvisible is growing faster (0% against -100% a year earlier).
More: Skinvisible earnings · how Skinvisible makes money · Bolt Biotherapeutics earnings · how Bolt Biotherapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.